Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-03-14 @ 4:58 PM
Study NCT ID:
NCT02203604
Status:
TERMINATED
Last Update Posted:
2023-07-18
First Post:
2014-07-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Sponsor:
CINJRegulatory
Organization: